This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Oscar H. Del Brutto, MD
Department of Neurology, Luis Vernaza Hospital, Guayaquil, Ecuador

Arch Neurol. 1996;53(4):295-296.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In reply

We would like to answer that the undue concerns of Garg and Agrawal are typical of those who are not familiar with the medical treatment of neurocysticercosis. As several different aspects were commented on in their letter, I would like to analyze them step by step.

1. They stated that patients with epilepsy due to single viable cysticerci (hypodense cystic lesions) have not been reported. I would like to bring to their attention our article¹ on epilepsy due to neurocysticercosis published more than 3 years ago. In that study, 30 (15%) of 203 patients had epilepsy caused by a single hypodense cystic lesion. In addition, several reports on drug therapy for parenchymal neurocysticercosis had included patients with single hypodense cystic lesions who presented with epilepsy as the primary or sole manifestation of the disease.^2-5

2. Garg and Agrawal stated that "several" deaths have occurred as the result . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?